Juvenile Neuronal Ceroid Lipofuscinosis
Neurogene Halts Development of Batten Gene Therapy NGN-101 Following FDA Denial
Neurogene, Batten disease, gene therapy, NGN-101, FDA denial, rare disease research
Actionable Insights Powered by AI
Neurogene, Batten disease, gene therapy, NGN-101, FDA denial, rare disease research